| Dr Sarah H Abdelsamad, MD | |
|
18101 Oakwood Blvd, Dearborn, MI 48124-4089 | |
| (313) 970-0017 | |
| Not Available |
| Full Name | Dr Sarah H Abdelsamad |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 18101 Oakwood Blvd, Dearborn, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518451236 | NPI | - | NPPES |
| 123 | Other | MI | OUT SIDE |
| 98887E3III | Other | PRIVITE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 4301115484 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah H Abdelsamad, MD 3096 Lindenwood Dr, Dearborn, MI 48120-1312 Ph: (313) 970-0017 | Dr Sarah H Abdelsamad, MD 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (313) 970-0017 |
News Archive
Absorption Systems, a leader in testing drugs for ADMET, announced today that its GLP facility in San Diego, Calif., for preclinical testing of drugs, biologics and medical devices received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International.
Tribal, local, state, federal and other leaders in the field will share best practices and current research with more than 700 delegates already registered, including participants from 32 countries at the International Swine Flu Conference. Priority will be placed on identifying the responsibilities of various stakeholders in order to improve global communication coordination and collaboration
Amgen today announced top-line results from a randomized Phase 3 trial evaluating Vectibix as a first-line treatment in patients with recurrent and/or metastatic squamous cell head and neck cancer. The data showed the addition of Vectibix to platinum-based chemotherapy did not result in a statistically significant improvement in overall survival, the primary endpoint, compared to chemotherapy alone.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 5 days ago
Albagir Mohamed Alarabi, M.D Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Rama V Thyagarajan, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd Ste 101, Medical Office Building, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 | |
Adeeb M Atassi, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 18181 Oakwood Blvd, Suite Number 208, Dearborn, MI 48124 Phone: 313-563-3332 | |
Mihaela A. Lupu, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Ste 208, Dearborn, MI 48124 Phone: 313-271-5670 Fax: 313-271-1053 | |
Violet Asfour, Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 18100 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2578 | |
Raed Haddad, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9720 Dix, Ste B, Dearborn, MI 48120 Phone: 313-843-1973 Fax: 313-843-1961 | |
Dr. Denise Kirsch, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd Ste 101, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 |